Your browser doesn't support javascript.
Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy.
Kitahara, Asako; Ebihara, Akinori; Obayashi, Shohei; Horio, Yukihiro; Ono, Yoshitaka; Yoshikawa, Tomohiro; Okada, Naoki; Tanaka, Jun; Takiguchi, Hiroto; Hayama, Naoki; Ito, Yoko; Oguma, Tsuyoshi; Kuwahira, Ichiro; Asano, Koichiro.
  • Kitahara A; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Ebihara A; Division of Pulmonary Medicine, Department of Medicine, Tokai University Tokyo Hospital, Japan.
  • Obayashi S; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Horio Y; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Ono Y; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Yoshikawa T; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Okada N; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Tanaka J; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Takiguchi H; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Hayama N; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Ito Y; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Oguma T; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
  • Kuwahira I; Division of Pulmonary Medicine, Department of Medicine, Tokai University Tokyo Hospital, Japan.
  • Asano K; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.
Intern Med ; 61(8): 1219-1223, 2022 Apr 15.
Artículo en Inglés | MEDLINE | ID: covidwho-2089579
ABSTRACT
A 44-year-old man developed coronavirus disease 2019 (COVID-19) pneumonia during immunochemotherapy consisting of carboplatin, paclitaxel, and pembrolizumab for non-small cell lung cancer. Low-grade fever, followed by mild hypoxemia, and febrile neutropenia, were observed, and granulocyte colony-stimulating factor (G-CSF) was administered until the recovery of neutropenia, when he developed a high fever, severe hypoxemia, and hypotension accompanied by consolidation in the bilateral lungs. His conditions promptly improved after treatment including hydrocortisone and the primary and metastatic tumors remained regressed for 10 months without further treatment. Post-COVID-19 organizing pneumonia during cancer immunochemotherapy can be aggravated by immune-checkpoint inhibitors and G-CSF.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / COVID-19 / Neoplasias Pulmonares Tipo de estudio: Reporte de caso Tópicos: Covid persistente Límite: Adulto / Humanos / Masculino Idioma: Inglés Revista: Intern Med Asunto de la revista: Medicina Interna Año: 2022 Tipo del documento: Artículo País de afiliación: Internalmedicine.8928-21

Similares

MEDLINE
LILACS
LIS
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / COVID-19 / Neoplasias Pulmonares Tipo de estudio: Reporte de caso Tópicos: Covid persistente Límite: Adulto / Humanos / Masculino Idioma: Inglés Revista: Intern Med Asunto de la revista: Medicina Interna Año: 2022 Tipo del documento: Artículo País de afiliación: Internalmedicine.8928-21